Global Peptide CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 121

Published Date: 04 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Peptide CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Peptide CDMO services refer to peptide drug development and manufacturing outsourcing services. Polypeptides are short-chain proteins composed of amino acids and have a wide range of biological activities and pharmacological applications.

Peptide CDMO services usually cover the following aspects: peptide synthesis, process development, quality control, scale production, injection preparation. By choosing peptide CDMO services, the development and manufacture of peptide drugs can be handed over to professional institutions, thereby saving time, reducing costs, and ensuring product quality and compliance.

The Global Info Research report includes an overview of the development of the Peptide CDMO Services industry chain, the market status of Clinical Treatment (Small Molecule CDMO, Macro-molecular CDMO), Medical Research (Small Molecule CDMO, Macro-molecular CDMO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peptide CDMO Services.

Regionally, the report analyzes the Peptide CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peptide CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Peptide CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peptide CDMO Services industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small Molecule CDMO, Macro-molecular CDMO).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peptide CDMO Services market.

Regional Analysis: The report involves examining the Peptide CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peptide CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Peptide CDMO Services:
Company Analysis: Report covers individual Peptide CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peptide CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Treatment, Medical Research).

Technology Analysis: Report covers specific technologies relevant to Peptide CDMO Services. It assesses the current state, advancements, and potential future developments in Peptide CDMO Services areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peptide CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Peptide CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Small Molecule CDMO
Macro-molecular CDMO

Market segment by Application
Clinical Treatment
Medical Research
Commercial Production

Market segment by players, this report covers
Incyte
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Peptide CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide CDMO Services, with revenue, gross margin and global market share of Peptide CDMO Services from 2018 to 2023.
Chapter 3, the Peptide CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Peptide CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide CDMO Services.
Chapter 13, to describe Peptide CDMO Services research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Peptide CDMO Services
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Peptide CDMO Services by Type
        1.3.1 Overview: Global Peptide CDMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Peptide CDMO Services Consumption Value Market Share by Type in 2022
        1.3.3 Small Molecule CDMO
        1.3.4 Macro-molecular CDMO
    1.4 Global Peptide CDMO Services Market by Application
        1.4.1 Overview: Global Peptide CDMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Clinical Treatment
        1.4.3 Medical Research
        1.4.4 Commercial Production
    1.5 Global Peptide CDMO Services Market Size & Forecast
    1.6 Global Peptide CDMO Services Market Size and Forecast by Region
        1.6.1 Global Peptide CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Peptide CDMO Services Market Size by Region, (2018-2029)
        1.6.3 North America Peptide CDMO Services Market Size and Prospect (2018-2029)
        1.6.4 Europe Peptide CDMO Services Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Peptide CDMO Services Market Size and Prospect (2018-2029)
        1.6.6 South America Peptide CDMO Services Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Peptide CDMO Services Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Incyte
        2.1.1 Incyte Details
        2.1.2 Incyte Major Business
        2.1.3 Incyte Peptide CDMO Services Product and Solutions
        2.1.4 Incyte Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Incyte Recent Developments and Future Plans
    2.2 Gliead
        2.2.1 Gliead Details
        2.2.2 Gliead Major Business
        2.2.3 Gliead Peptide CDMO Services Product and Solutions
        2.2.4 Gliead Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Gliead Recent Developments and Future Plans
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Peptide CDMO Services Product and Solutions
        2.3.4 Boehringer Ingelheim Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.4 Vertex
        2.4.1 Vertex Details
        2.4.2 Vertex Major Business
        2.4.3 Vertex Peptide CDMO Services Product and Solutions
        2.4.4 Vertex Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Vertex Recent Developments and Future Plans
    2.5 Mirati Therapeutics
        2.5.1 Mirati Therapeutics Details
        2.5.2 Mirati Therapeutics Major Business
        2.5.3 Mirati Therapeutics Peptide CDMO Services Product and Solutions
        2.5.4 Mirati Therapeutics Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Mirati Therapeutics Recent Developments and Future Plans
    2.6 AMPAC
        2.6.1 AMPAC Details
        2.6.2 AMPAC Major Business
        2.6.3 AMPAC Peptide CDMO Services Product and Solutions
        2.6.4 AMPAC Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 AMPAC Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Peptide CDMO Services Product and Solutions
        2.7.4 Pfizer Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Pfizer Recent Developments and Future Plans
    2.8 Polypeptide
        2.8.1 Polypeptide Details
        2.8.2 Polypeptide Major Business
        2.8.3 Polypeptide Peptide CDMO Services Product and Solutions
        2.8.4 Polypeptide Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Polypeptide Recent Developments and Future Plans
    2.9 Bachem
        2.9.1 Bachem Details
        2.9.2 Bachem Major Business
        2.9.3 Bachem Peptide CDMO Services Product and Solutions
        2.9.4 Bachem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bachem Recent Developments and Future Plans
    2.10 Merck
        2.10.1 Merck Details
        2.10.2 Merck Major Business
        2.10.3 Merck Peptide CDMO Services Product and Solutions
        2.10.4 Merck Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Merck Recent Developments and Future Plans
    2.11 Asymchem
        2.11.1 Asymchem Details
        2.11.2 Asymchem Major Business
        2.11.3 Asymchem Peptide CDMO Services Product and Solutions
        2.11.4 Asymchem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Asymchem Recent Developments and Future Plans
    2.12 Zhejiang Jiuzhou Pharmaceutical
        2.12.1 Zhejiang Jiuzhou Pharmaceutical Details
        2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
        2.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product and Solutions
        2.12.4 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
    2.13 Sinopep
        2.13.1 Sinopep Details
        2.13.2 Sinopep Major Business
        2.13.3 Sinopep Peptide CDMO Services Product and Solutions
        2.13.4 Sinopep Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sinopep Recent Developments and Future Plans
    2.14 Frontier Biotechnologies
        2.14.1 Frontier Biotechnologies Details
        2.14.2 Frontier Biotechnologies Major Business
        2.14.3 Frontier Biotechnologies Peptide CDMO Services Product and Solutions
        2.14.4 Frontier Biotechnologies Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Frontier Biotechnologies Recent Developments and Future Plans
    2.15 JYMed
        2.15.1 JYMed Details
        2.15.2 JYMed Major Business
        2.15.3 JYMed Peptide CDMO Services Product and Solutions
        2.15.4 JYMed Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 JYMed Recent Developments and Future Plans
    2.16 Chengdu Shengnuo Biotechnology
        2.16.1 Chengdu Shengnuo Biotechnology Details
        2.16.2 Chengdu Shengnuo Biotechnology Major Business
        2.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Product and Solutions
        2.16.4 Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Chengdu Shengnuo Biotechnology Recent Developments and Future Plans
    2.17 Shanghai Soho-Yiming Pharmaceuticals
        2.17.1 Shanghai Soho-Yiming Pharmaceuticals Details
        2.17.2 Shanghai Soho-Yiming Pharmaceuticals Major Business
        2.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product and Solutions
        2.17.4 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments and Future Plans
    2.18 Chinese Peptide Company
        2.18.1 Chinese Peptide Company Details
        2.18.2 Chinese Peptide Company Major Business
        2.18.3 Chinese Peptide Company Peptide CDMO Services Product and Solutions
        2.18.4 Chinese Peptide Company Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Chinese Peptide Company Recent Developments and Future Plans
    2.19 Ambio Pharmaceuticals
        2.19.1 Ambio Pharmaceuticals Details
        2.19.2 Ambio Pharmaceuticals Major Business
        2.19.3 Ambio Pharmaceuticals Peptide CDMO Services Product and Solutions
        2.19.4 Ambio Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Ambio Pharmaceuticals Recent Developments and Future Plans
    2.20 Zhejiang Peptites Biotech
        2.20.1 Zhejiang Peptites Biotech Details
        2.20.2 Zhejiang Peptites Biotech Major Business
        2.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Product and Solutions
        2.20.4 Zhejiang Peptites Biotech Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Zhejiang Peptites Biotech Recent Developments and Future Plans
    2.21 STA Pharmaceutical
        2.21.1 STA Pharmaceutical Details
        2.21.2 STA Pharmaceutical Major Business
        2.21.3 STA Pharmaceutical Peptide CDMO Services Product and Solutions
        2.21.4 STA Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
        2.21.5 STA Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Peptide CDMO Services Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Peptide CDMO Services by Company Revenue
        3.2.2 Top 3 Peptide CDMO Services Players Market Share in 2022
        3.2.3 Top 6 Peptide CDMO Services Players Market Share in 2022
    3.3 Peptide CDMO Services Market: Overall Company Footprint Analysis
        3.3.1 Peptide CDMO Services Market: Region Footprint
        3.3.2 Peptide CDMO Services Market: Company Product Type Footprint
        3.3.3 Peptide CDMO Services Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Peptide CDMO Services Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Peptide CDMO Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Peptide CDMO Services Consumption Value Market Share by Application (2018-2023)
    5.2 Global Peptide CDMO Services Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Peptide CDMO Services Consumption Value by Type (2018-2029)
    6.2 North America Peptide CDMO Services Consumption Value by Application (2018-2029)
    6.3 North America Peptide CDMO Services Market Size by Country
        6.3.1 North America Peptide CDMO Services Consumption Value by Country (2018-2029)
        6.3.2 United States Peptide CDMO Services Market Size and Forecast (2018-2029)
        6.3.3 Canada Peptide CDMO Services Market Size and Forecast (2018-2029)
        6.3.4 Mexico Peptide CDMO Services Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Peptide CDMO Services Consumption Value by Type (2018-2029)
    7.2 Europe Peptide CDMO Services Consumption Value by Application (2018-2029)
    7.3 Europe Peptide CDMO Services Market Size by Country
        7.3.1 Europe Peptide CDMO Services Consumption Value by Country (2018-2029)
        7.3.2 Germany Peptide CDMO Services Market Size and Forecast (2018-2029)
        7.3.3 France Peptide CDMO Services Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Peptide CDMO Services Market Size and Forecast (2018-2029)
        7.3.5 Russia Peptide CDMO Services Market Size and Forecast (2018-2029)
        7.3.6 Italy Peptide CDMO Services Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Peptide CDMO Services Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Peptide CDMO Services Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Peptide CDMO Services Market Size by Region
        8.3.1 Asia-Pacific Peptide CDMO Services Consumption Value by Region (2018-2029)
        8.3.2 China Peptide CDMO Services Market Size and Forecast (2018-2029)
        8.3.3 Japan Peptide CDMO Services Market Size and Forecast (2018-2029)
        8.3.4 South Korea Peptide CDMO Services Market Size and Forecast (2018-2029)
        8.3.5 India Peptide CDMO Services Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Peptide CDMO Services Market Size and Forecast (2018-2029)
        8.3.7 Australia Peptide CDMO Services Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Peptide CDMO Services Consumption Value by Type (2018-2029)
    9.2 South America Peptide CDMO Services Consumption Value by Application (2018-2029)
    9.3 South America Peptide CDMO Services Market Size by Country
        9.3.1 South America Peptide CDMO Services Consumption Value by Country (2018-2029)
        9.3.2 Brazil Peptide CDMO Services Market Size and Forecast (2018-2029)
        9.3.3 Argentina Peptide CDMO Services Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Peptide CDMO Services Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Peptide CDMO Services Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Peptide CDMO Services Market Size by Country
        10.3.1 Middle East & Africa Peptide CDMO Services Consumption Value by Country (2018-2029)
        10.3.2 Turkey Peptide CDMO Services Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Peptide CDMO Services Market Size and Forecast (2018-2029)
        10.3.4 UAE Peptide CDMO Services Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Peptide CDMO Services Market Drivers
    11.2 Peptide CDMO Services Market Restraints
    11.3 Peptide CDMO Services Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Peptide CDMO Services Industry Chain
    12.2 Peptide CDMO Services Upstream Analysis
    12.3 Peptide CDMO Services Midstream Analysis
    12.4 Peptide CDMO Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peptide CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Peptide CDMO Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Peptide CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Peptide CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Incyte Company Information, Head Office, and Major Competitors
    Table 6. Incyte Major Business
    Table 7. Incyte Peptide CDMO Services Product and Solutions
    Table 8. Incyte Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Incyte Recent Developments and Future Plans
    Table 10. Gliead Company Information, Head Office, and Major Competitors
    Table 11. Gliead Major Business
    Table 12. Gliead Peptide CDMO Services Product and Solutions
    Table 13. Gliead Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Gliead Recent Developments and Future Plans
    Table 15. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 16. Boehringer Ingelheim Major Business
    Table 17. Boehringer Ingelheim Peptide CDMO Services Product and Solutions
    Table 18. Boehringer Ingelheim Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Boehringer Ingelheim Recent Developments and Future Plans
    Table 20. Vertex Company Information, Head Office, and Major Competitors
    Table 21. Vertex Major Business
    Table 22. Vertex Peptide CDMO Services Product and Solutions
    Table 23. Vertex Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Vertex Recent Developments and Future Plans
    Table 25. Mirati Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. Mirati Therapeutics Major Business
    Table 27. Mirati Therapeutics Peptide CDMO Services Product and Solutions
    Table 28. Mirati Therapeutics Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Mirati Therapeutics Recent Developments and Future Plans
    Table 30. AMPAC Company Information, Head Office, and Major Competitors
    Table 31. AMPAC Major Business
    Table 32. AMPAC Peptide CDMO Services Product and Solutions
    Table 33. AMPAC Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. AMPAC Recent Developments and Future Plans
    Table 35. Pfizer Company Information, Head Office, and Major Competitors
    Table 36. Pfizer Major Business
    Table 37. Pfizer Peptide CDMO Services Product and Solutions
    Table 38. Pfizer Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Pfizer Recent Developments and Future Plans
    Table 40. Polypeptide Company Information, Head Office, and Major Competitors
    Table 41. Polypeptide Major Business
    Table 42. Polypeptide Peptide CDMO Services Product and Solutions
    Table 43. Polypeptide Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Polypeptide Recent Developments and Future Plans
    Table 45. Bachem Company Information, Head Office, and Major Competitors
    Table 46. Bachem Major Business
    Table 47. Bachem Peptide CDMO Services Product and Solutions
    Table 48. Bachem Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Bachem Recent Developments and Future Plans
    Table 50. Merck Company Information, Head Office, and Major Competitors
    Table 51. Merck Major Business
    Table 52. Merck Peptide CDMO Services Product and Solutions
    Table 53. Merck Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Merck Recent Developments and Future Plans
    Table 55. Asymchem Company Information, Head Office, and Major Competitors
    Table 56. Asymchem Major Business
    Table 57. Asymchem Peptide CDMO Services Product and Solutions
    Table 58. Asymchem Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Asymchem Recent Developments and Future Plans
    Table 60. Zhejiang Jiuzhou Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 61. Zhejiang Jiuzhou Pharmaceutical Major Business
    Table 62. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product and Solutions
    Table 63. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
    Table 65. Sinopep Company Information, Head Office, and Major Competitors
    Table 66. Sinopep Major Business
    Table 67. Sinopep Peptide CDMO Services Product and Solutions
    Table 68. Sinopep Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Sinopep Recent Developments and Future Plans
    Table 70. Frontier Biotechnologies Company Information, Head Office, and Major Competitors
    Table 71. Frontier Biotechnologies Major Business
    Table 72. Frontier Biotechnologies Peptide CDMO Services Product and Solutions
    Table 73. Frontier Biotechnologies Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Frontier Biotechnologies Recent Developments and Future Plans
    Table 75. JYMed Company Information, Head Office, and Major Competitors
    Table 76. JYMed Major Business
    Table 77. JYMed Peptide CDMO Services Product and Solutions
    Table 78. JYMed Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. JYMed Recent Developments and Future Plans
    Table 80. Chengdu Shengnuo Biotechnology Company Information, Head Office, and Major Competitors
    Table 81. Chengdu Shengnuo Biotechnology Major Business
    Table 82. Chengdu Shengnuo Biotechnology Peptide CDMO Services Product and Solutions
    Table 83. Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Chengdu Shengnuo Biotechnology Recent Developments and Future Plans
    Table 85. Shanghai Soho-Yiming Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 86. Shanghai Soho-Yiming Pharmaceuticals Major Business
    Table 87. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product and Solutions
    Table 88. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Shanghai Soho-Yiming Pharmaceuticals Recent Developments and Future Plans
    Table 90. Chinese Peptide Company Company Information, Head Office, and Major Competitors
    Table 91. Chinese Peptide Company Major Business
    Table 92. Chinese Peptide Company Peptide CDMO Services Product and Solutions
    Table 93. Chinese Peptide Company Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Chinese Peptide Company Recent Developments and Future Plans
    Table 95. Ambio Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 96. Ambio Pharmaceuticals Major Business
    Table 97. Ambio Pharmaceuticals Peptide CDMO Services Product and Solutions
    Table 98. Ambio Pharmaceuticals Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Ambio Pharmaceuticals Recent Developments and Future Plans
    Table 100. Zhejiang Peptites Biotech Company Information, Head Office, and Major Competitors
    Table 101. Zhejiang Peptites Biotech Major Business
    Table 102. Zhejiang Peptites Biotech Peptide CDMO Services Product and Solutions
    Table 103. Zhejiang Peptites Biotech Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. Zhejiang Peptites Biotech Recent Developments and Future Plans
    Table 105. STA Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 106. STA Pharmaceutical Major Business
    Table 107. STA Pharmaceutical Peptide CDMO Services Product and Solutions
    Table 108. STA Pharmaceutical Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 109. STA Pharmaceutical Recent Developments and Future Plans
    Table 110. Global Peptide CDMO Services Revenue (USD Million) by Players (2018-2023)
    Table 111. Global Peptide CDMO Services Revenue Share by Players (2018-2023)
    Table 112. Breakdown of Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 113. Market Position of Players in Peptide CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 114. Head Office of Key Peptide CDMO Services Players
    Table 115. Peptide CDMO Services Market: Company Product Type Footprint
    Table 116. Peptide CDMO Services Market: Company Product Application Footprint
    Table 117. Peptide CDMO Services New Market Entrants and Barriers to Market Entry
    Table 118. Peptide CDMO Services Mergers, Acquisition, Agreements, and Collaborations
    Table 119. Global Peptide CDMO Services Consumption Value (USD Million) by Type (2018-2023)
    Table 120. Global Peptide CDMO Services Consumption Value Share by Type (2018-2023)
    Table 121. Global Peptide CDMO Services Consumption Value Forecast by Type (2024-2029)
    Table 122. Global Peptide CDMO Services Consumption Value by Application (2018-2023)
    Table 123. Global Peptide CDMO Services Consumption Value Forecast by Application (2024-2029)
    Table 124. North America Peptide CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 125. North America Peptide CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 126. North America Peptide CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 127. North America Peptide CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 128. North America Peptide CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 129. North America Peptide CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 130. Europe Peptide CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 131. Europe Peptide CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 132. Europe Peptide CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 133. Europe Peptide CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 134. Europe Peptide CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 135. Europe Peptide CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 136. Asia-Pacific Peptide CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 137. Asia-Pacific Peptide CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 138. Asia-Pacific Peptide CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 139. Asia-Pacific Peptide CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 140. Asia-Pacific Peptide CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 141. Asia-Pacific Peptide CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
    Table 142. South America Peptide CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 143. South America Peptide CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 144. South America Peptide CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 145. South America Peptide CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 146. South America Peptide CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 147. South America Peptide CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 148. Middle East & Africa Peptide CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
    Table 149. Middle East & Africa Peptide CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
    Table 150. Middle East & Africa Peptide CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
    Table 151. Middle East & Africa Peptide CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
    Table 152. Middle East & Africa Peptide CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
    Table 153. Middle East & Africa Peptide CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
    Table 154. Peptide CDMO Services Raw Material
    Table 155. Key Suppliers of Peptide CDMO Services Raw Materials
List of Figures
    Figure 1. Peptide CDMO Services Picture
    Figure 2. Global Peptide CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Peptide CDMO Services Consumption Value Market Share by Type in 2022
    Figure 4. Small Molecule CDMO
    Figure 5. Macro-molecular CDMO
    Figure 6. Global Peptide CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Peptide CDMO Services Consumption Value Market Share by Application in 2022
    Figure 8. Clinical Treatment Picture
    Figure 9. Medical Research Picture
    Figure 10. Commercial Production Picture
    Figure 11. Global Peptide CDMO Services Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Peptide CDMO Services Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Peptide CDMO Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Peptide CDMO Services Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Peptide CDMO Services Consumption Value Market Share by Region in 2022
    Figure 16. North America Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Peptide CDMO Services Revenue Share by Players in 2022
    Figure 22. Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Peptide CDMO Services Market Share in 2022
    Figure 24. Global Top 6 Players Peptide CDMO Services Market Share in 2022
    Figure 25. Global Peptide CDMO Services Consumption Value Share by Type (2018-2023)
    Figure 26. Global Peptide CDMO Services Market Share Forecast by Type (2024-2029)
    Figure 27. Global Peptide CDMO Services Consumption Value Share by Application (2018-2023)
    Figure 28. Global Peptide CDMO Services Market Share Forecast by Application (2024-2029)
    Figure 29. North America Peptide CDMO Services Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Peptide CDMO Services Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Peptide CDMO Services Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Peptide CDMO Services Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Peptide CDMO Services Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Peptide CDMO Services Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Peptide CDMO Services Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Peptide CDMO Services Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Peptide CDMO Services Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Peptide CDMO Services Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Peptide CDMO Services Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Peptide CDMO Services Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Peptide CDMO Services Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Peptide CDMO Services Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Peptide CDMO Services Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Peptide CDMO Services Consumption Value (2018-2029) & (USD Million)
    Figure 63. Peptide CDMO Services Market Drivers
    Figure 64. Peptide CDMO Services Market Restraints
    Figure 65. Peptide CDMO Services Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Peptide CDMO Services in 2022
    Figure 68. Manufacturing Process Analysis of Peptide CDMO Services
    Figure 69. Peptide CDMO Services Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Incyte
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical

Related Reports

Global Peptide CDMO Services Supply, Demand and Key Producers, 2023-2029

Global Peptide CDMO Services Supply, Demand and Key Producers, 2023-2029

date 04 Aug 2023

date Medical Care

The global Peptide CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Peptide CDMO Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Peptide CDMO Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Peptide CDMO Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Peptide CDMO Services

Custom Peptide CDMO Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>